Could less radiation be safer? new trial aims to cut side effects after head and neck cancer surgery

NCT ID NCT07058805

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This phase II trial tests whether a personalized, reduced-volume radiation plan can safely lower side effects after surgery for head and neck cancer. About 50 patients will receive radiation only to high-risk areas, skipping some traditionally treated zones. The goal is to see if this approach keeps cancer from returning while reducing treatment burden.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Compartmentalized postoperative radiotherapy (radiation therapy tailored to each patient's risk)
What this could lead to
If successful, this approach could reduce side effects from radiotherapy after head and neck cancer surgery, making recovery easier without raising the risk of cancer coming back.
What could go wrong
This is a small, early-phase trial with only 50 participants, so results may not apply to everyone. There is a risk that omitting some radiation areas could lead to cancer recurrence in those spots.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Inselspital, Bern University Hospital

    RECRUITING

    Bern, 3010, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University Hospital of Basel

    RECRUITING

    Basel, 4031, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University Hospital of Zurich

    RECRUITING

    Zurich, 8091, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.